On a Mission to Transform Early Cardiac Diagnostics

Introducing CADScor®System- an advanced acoustic-based diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care.*

Learn more about CADScor®System

Use CADScor®System to Rule-Out Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*

Non-invasive and radiation-free assessment for early rule-out of significant CAD

Can help save costs of more advanced CAD diagnostics in up to 35% of patients¹

Rapid and easy to use, with clear results at point of care

Quickly and easily rule-out significant CAD with at least 96% Confidence (Negative Predictive Value) ¹

CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. The system calculates a patient-specific CAD-score, and couples it with risk factors to rapidly indicate the patient’s risk of significant coronary stenosis for immediate risk stratification, prior to potential secondary evaluation.1 CADScor®System has been used in over 29,000 patient assessments2 and has CE-marking and FDA De Novo clearance.

Learn more about CADScor®System
Physicians’ Experiences Using CADScor®System
Explore customer feedback
Schedule a Demo of CADScor®System

Schedule a free demo of CADScor® System and learn how to quickly and easily rule out significant CAD in symptomatic patients at point of care.*

Book a CADScor®System demo

Latest News

See all news
June 9, 2023

Announcement from Acarix's extra general meeting

May 22, 2023

Notice of Extra General Meeting in Acarix AB


Latest Press Releases

See all press

  1. User manual US-FDA v.12.Y, prevalence 10,7%
  2. Based on commercial patch use since 2017
*Rule-out with at least 96% confidence (NPV)